Cargando…
Steroid Ligands, the Forgotten Triggers of Nuclear Receptor Action; Implications for Acquired Resistance to Endocrine Therapy
PURPOSE: There is strong epidemiologic evidence indicating that estrogens may not be the sole steroid drivers of breast cancer. We hypothesize that abundant adrenal androgenic steroid precursors, acting via the androgen receptor (AR), promote an endocrine-resistant breast cancer phenotype. EXPERIMEN...
Autores principales: | Bleach, Rachel, Madden, Stephen F., Hawley, James, Charmsaz, Sara, Selli, Cigdem, Sheehan, Katherine M., Young, Leonie S., Sims, Andrew H., Souček, Pavel, Hill, Arnold D., McIlroy, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401529/ https://www.ncbi.nlm.nih.gov/pubmed/34016642 http://dx.doi.org/10.1158/1078-0432.CCR-20-4135 |
Ejemplares similares
-
The Divergent Function of Androgen Receptor in Breast Cancer; Analysis of Steroid Mediators and Tumor Intracrinology
por: Bleach, Rachel, et al.
Publicado: (2018) -
Growth Hormone/Insulin Growth Factor Axis in Sex Steroid Associated Disorders and Related Cancers
por: Bleach, Rachel, et al.
Publicado: (2021) -
S100β as a serum marker in endocrine resistant breast cancer
por: Charmsaz, Sara, et al.
Publicado: (2017) -
Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkers
por: Selli, Cigdem, et al.
Publicado: (2016) -
Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer
por: Ali, Azlena, et al.
Publicado: (2015)